Likewise, the prevalence of insulinresistance (evaluated by the HOMA-IR index and fasting insulin level) is higheramong women with polycystic ovary syndrome and OSA compared to women withpolycystic ovary syndrome without OSA, after controlling for BMI and otherfactors. This evidence concerns the gene INS and obstructive sleep apnea syndrome.